HUXLEY; Philip
Patent Applications and Registrations
Patent applications and USPTO patent grants for HUXLEY; Philip.The latest application filed is for "bicyclic peptide ligands specific for epha2".
- HUXLEY; Philip - Cambridge GB
- Huxley; Philip - Oxfordshire GB
- Huxley; Philip - Oxon GB
- Huxley; Philip - Freeland GB
- Huxley; Philip - Abingdon GB
- Huxley; Philip - Oxford GB
- Huxley; Philip - Chessington GB2
| Patent | Date |
|---|---|
| Bicyclic Peptide Ligands Specific For Epha2 App 20220289792 - CHEN; Liuhong ; et al. | 2022-09-15 |
| CD200 mutants and its uses Grant 11,203,628 - Huxley , et al. December 21, 2 | 2021-12-21 |
| Cd200 Mutants And Its Uses App 20190367580 - HUXLEY; Philip ; et al. | 2019-12-05 |
| BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2 App 20190184025 - Chen; Liuhong ; et al. | 2019-06-20 |
| Cycloalkyl Amine Compounds App 20150057443 - Huxley; Philip ; et al. | 2015-02-26 |
| Novel Compounds App 20130023567 - Potter; Gerard A. ; et al. | 2013-01-24 |
| Compounds Grant 8,236,827 - Potter , et al. August 7, 2 | 2012-08-07 |
| Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases Grant 8,178,530 - Andrews , et al. May 15, 2 | 2012-05-15 |
| Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases Grant 8,173,656 - Andrews , et al. May 8, 2 | 2012-05-08 |
| Imidazolopyrazine Compounds Useful For The Treatment Of Degenerative And Inflammatory Diseases App 20110218178 - Andrews; Martin James Inglis ; et al. | 2011-09-08 |
| Imidazolopyrazine Compounds Useful For The Treatment Of Degenerative And Inflammatory Diseases App 20110092497 - Andrews; Martin James Inglis ; et al. | 2011-04-21 |
| Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases Grant 7,893,058 - Andrews , et al. February 22, 2 | 2011-02-22 |
| Novel Compounds App 20100168180 - Potter; Gerard Andrew ; et al. | 2010-07-01 |
| Tetracyclic immunomodulatory compounds Grant 7,674,906 - Matthews , et al. March 9, 2 | 2010-03-09 |
| Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases App 20070281943 - Andrews; Martin James Inglis ; et al. | 2007-12-06 |
| Immunomodulatory compounds Grant 7,291,612 - Matthews , et al. November 6, 2 | 2007-11-06 |
| Immunomodulatory compounds App 20060217411 - Matthews; Ian Richard ; et al. | 2006-09-28 |
| Immunomodulatory compounds Grant 7,081,456 - Matthews , et al. July 25, 2 | 2006-07-25 |
| Tetracylic immunomodulatory compounds App 20060035919 - Matthews; Lan Richard ; et al. | 2006-02-16 |
| Immunomodulatory compounds App 20050203118 - Matthews, Ian Richard ; et al. | 2005-09-15 |
| Cytostatic agents Grant 6,790,834 - Pearson , et al. September 14, 2 | 2004-09-14 |
| Immunomodulatory compounds App 20040116461 - Matthews, Ian Richard ; et al. | 2004-06-17 |
| Substituted azetidin-2-ones as cysteine protease inhibitors Grant 6,569,847 - Singh , et al. May 27, 2 | 2003-05-27 |
| Matrix metalloproteinase inhibitors Grant 5,917,090 - Huxley , et al. June 29, 1 | 1999-06-29 |
| Graphics system with color space double buffering Grant 5,742,796 - Huxley April 21, 1 | 1998-04-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 